J Knee Surg 2022; 35(06): 661-667
DOI: 10.1055/s-0040-1716503
Original Article

Predictors of Staphylococcus Aureus Nasal Colonization in Joint Arthroplasty Patients

Erik J. Stapleton
1   Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Valley Stream, Valley Stream, New York
,
Brandon Petrone
1   Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Valley Stream, Valley Stream, New York
,
Theofanis Zois
2   Department of Orthopaedic Surgery, Northwell Health Orthopedic Institute, Lenox Hill Hospital, New York, New York
,
Vivian Papas
2   Department of Orthopaedic Surgery, Northwell Health Orthopedic Institute, Lenox Hill Hospital, New York, New York
,
1   Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Valley Stream, Valley Stream, New York
,
Evan Green
1   Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Valley Stream, Valley Stream, New York
,
Giles R. Scuderi
2   Department of Orthopaedic Surgery, Northwell Health Orthopedic Institute, Lenox Hill Hospital, New York, New York
› Author Affiliations

Abstract

Early identification and treatment of Staphylococcus aureus (S. aureus) nasal colonization can reduce the risk of prosthetic joint infection. The purpose of this study was to evaluate patient-specific predictors for S. aureus nasal colonization in total joint arthroplasty patients to aid in preoperative screening protocols. A total of 2,147 arthroplasty patients who were preoperatively screened for S. aureus nasal colonization were retrospectively reviewed. Factors analyzed consisted of procedure type, primary diagnosis, gender, ethnicity, body mass index, the presence of chronic obstructive pulmonary disease, obstructive sleep apnea, hypertension, diabetes mellitus, use of immunosuppression medication, smoking history, and chronic kidney disease. Univariate and multivariate analyses were performed with significance p < 0.05 and 95% confidence intervals. Overall, 3.7% (79) of our cohort tested positive for methicillin-resistant Staphylococcus aureus (MRSA), and 23.2% (493) tested positive for methicillin-sensitive Staphylococcus aureus (MSSA). Independent predictors for MRSA colonization were of Hispanic ethnicity (p = 0.001, odds ratio [OR] 13.98, confidence interval [CI] 2.97–65.76), immunosuppression medication use (p = 0.006, OR 2.82, CI 1.35–5.87), and revision total hip arthroplasty (THA) procedure (p < 0.001, OR 7.51, CI 2.58–21.89). Independent predictors for MSSA colonization were body mass index (BMI) >35 (p = 0.002, OR 1.57, CI 1.19–2.1). Variables were found to be protective against MSSA colonization including female gender (p = 0.012, OR 0.76, CI 0.61–0.94), age 60 to 69 (p = 0.025, OR 0.75, CI 0.58–0.96), and age 70 to 79 (p = 0.002, OR 0.63, CI 0.47–0.84). Age, Hispanic ethnicity, gender, revision THA, use of immunosuppression medication, and elevated BMI were independent risk factors for S. aureus nasal colonization.



Publication History

Received: 01 April 2020

Accepted: 29 July 2020

Article published online:
17 September 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Center for Health Statistics N., Number of all-listed procedures for discharges from short-stay hospitals, by procedure category and age: United States. 2010 Accessed April 21, 2019 at: https://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf
  • 2 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 3 American Joint Replacement Registry. Improving orthopaedic care through data. Accessed December 28, 2019 at: https://www.ajrr.net/
  • 4 Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH. Periprosthetic infection due to resistant Staphylococci: serious problems on the horizon. In: Clinical Orthopaedics and Related Research. Vol. 467. New York, NY: Springer; 2009: 1732-1739
  • 5 Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91 (01) 128-133
  • 6 Bozic KJ, Kurtz SM, Lau E. et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010; 468 (01) 45-51
  • 7 Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplasty 2017; 32 (09) 2663-2668
  • 8 Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am 2013; 95 (24) 2177-2184
  • 9 Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012; 27 (Suppl. 08) 61-5.e1
  • 10 Kamath AF, Ong KL, Lau E. et al. Quantifying the burden of revision total joint arthroplasty for periprosthetic infection. J Arthroplasty 2015; 30 (09) 1492-1497
  • 11 Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23 (07) 984-991
  • 12 Levy DM, Wetters NG, Levine BR. Prevention of periprosthetic joint infections of the hip and knee. Am J Orthop 2016; 45 (05) E299-E307
  • 13 Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014; 27 (02) 302-345
  • 14 Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 1999; 81 (10) 1434-1445
  • 15 Walsh AL, Fields AC, Dieterich JD, Chen DD, Bronson MJ, Moucha CS. Risk factors for Staphylococcus aureus nasal colonization in joint arthroplasty patients. J Arthroplasty 2018; 33 (05) 1530-1533
  • 16 Kalra L, Camacho F, Whitener CJ. et al. Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. Am J Infect Control 2013; 41 (12) 1253-1257
  • 17 Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res 2013; 471 (07) 2383-2399
  • 18 Rao N, Cannella B, Crossett LS, Yates Jr AJ, McGough III R. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008; 466 (06) 1343-1348
  • 19 Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999; 27 (02) 97-132 , quiz 133–134, discussion 96
  • 20 Sporer SM, Rogers T, Abella L. Methicillin-resistant and methicillin-sensitive Staphylococcus aureus screening and decolonization to reduce surgical site infection in elective total joint arthroplasty. J Arthroplasty 2016; 31 (Suppl. 09) 144-147
  • 21 Price CS, Williams A, Philips G, Dayton M, Smith W, Morgan S. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res 2008; 466 (11) 2842-2847
  • 22 Kline S, Highness M, Herwaldt LA, Perl TM. Variable screening and decolonization protocols for Staphylococcus aureus carriage prior to surgical procedures. Infect Control Hosp Epidemiol 2014; 35 (07) 880-882
  • 23 Stambough JB, Nam D, Warren DK. et al. Decreased hospital costs and surgical site infection incidence with a universal decolonization protocol in primary total joint arthroplasty. J Arthroplasty 2017; 32 (03) 728-734.e1
  • 24 Courville XF, Tomek IM, Kirkland KB, Birhle M, Kantor SR, Finlayson SRG. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2012; 33 (02) 152-159
  • 25 Kerbel YE, Sunkerneni AR, Kirchner GJ, Prodromo JP, Moretti VM. The cost-effectiveness of preoperative Staphylococcus aureus screening and decolonization in total joint arthroplasty. J Arthroplasty 2018; 33 (7S): S191-S195
  • 26 Stirton J, Herron JS, Nandi S. Empiric treatment is less costly than Staphylococcus aureus screening and decolonization in total joint arthroplasty patients. Arthroplast Today 2017; 4 (03) 323-324
  • 27 Tübbicke A, Hübner C, Hübner N-O, Wegner C, Kramer A, Fleßa S. Cost comparison of MRSA screening and management—a decision tree analysis. BMC Health Serv Res 2012; 12 (01) 438
  • 28 Antonov NK, Garzon MC, Morel KD, Whittier S, Planet PJ, Lauren CT. High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population. Antimicrob Agents Chemother 2015; 59 (06) 3350-3356
  • 29 Chaturvedi P, Singh AK, Singh AK, Shukla S, Agarwal L. Prevalence of mupirocin resistant Staphylococcus aureus isolates among patients admitted to a tertiary care hospital. N Am J Med Sci 2014; 6 (08) 403-407
  • 30 Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17 (12) 811-813
  • 31 Baratz MD, Hallmark R, Odum SM, Springer BD. Twenty percent of patients may remain colonized with methicillin-resistant Staphylococcus aureus despite a decolonization protocol in patients undergoing elective total joint arthroplasty. Clin Orthop Relat Res 2015; 473 (07) 2283-2290